Fibromyalgia Clinical Trial
This study is an acceptability and feasibility study of two adjunctive interventions: group education with stretching; and group acupuncture. The study population will be women with primary fibromyalgia who have not previously used acupuncture in the last 3 months. Both interventions will be 10 weeks in length and will be conducted at the Oregon Health & Science University. The primary hypothesis is that both arms will be acceptable and feasible in the study population.
Status | Completed |
Enrollment | 431 |
Est. completion date | July 2015 |
Est. primary completion date | July 2015 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: 1. Having met American College of Rheumatology (1990) criteria for the diagnosis of fibromyalgia 2. Having a primary Traditional Chinese Medicine (TCM) diagnosis of either Liver Qi Stagnation, Qi and Blood Stagnation, or Qi and Blood Deficiency 3. Female gender 4. Reported average pain of 5 or higher over last week on a scale of 0 to 10 with ten indicating higher pain. 5. Willingness to limit the introduction or change of any medications or treatment modalities for control of fibromyalgia symptoms during the study 6. No TCM in last 3 months (including acupuncture, Chinese herbs or herbal tea pills, tuina (Chinese massage), shiatsu (Japanese massage), qigong and Oriental food therapy) 7. Ability to travel to the intervention and testing sites up to two times weekly 8. Being over 18 and under 75 years of age, and 9. Capability of giving informed consent. Exclusion Criteria: 1. Presence of a known coagulation abnormality, thrombocytopenia, or bleeding diathesis that may preclude the safe use of acupuncture; 2. Individuals with celiac disease 3. A score greater than 29 on the Beck Depression Inventory 4. Presence of concurrent autoimmune disease such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, that causes pain and could potentially confound the analysis; 5. Routine daily use of narcotic analgesics or history of substance abuse; 6. Concurrent participation in other therapeutic trials; 7. Pregnant and nursing mothers (verification of pregnancy status will be determined via a urine test); 8. Severe psychiatric illnesses (current schizophrenia, major depression with suicidal ideation, substance abuse within two years); 9. Are undergoing disability determination, or are involved in litigation related to fibromyalgia 10. Any impairment, activity or situation that in the judgment of the PI would prevent satisfactory completion of the study protocol 11. Cognitive behavioral therapy in the last 6 months. 12. Non-fluency in English |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Oregon Health & Science University | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
Oregon Health and Science University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Treatment Participation Rate | Rates of treatment attendance in both arms | 10 weeks | No |
Secondary | Drop out rate | Drop out rates in both arms at weeks 10 and 14 | 10 and 14 weeks | No |
Secondary | Completion of Evaluation Rates | Completion rates of questionnaires and examinations in both arms | Weeks 0, 5, 10 and 14 | No |
Secondary | Fibromyalgia Impact Questionnaire Revised | Comparing overall score of the Fibromyalgia Impact Questionnaire - Revised between the two arms over time. | Weeks 0, 5, 10, and 14 | No |
Secondary | Nociceptive Reflex Testing | Nociceptive Reflex will be tested at weeks 0, 5, 10 and 14. Changes in nociceptive reflex will be compared within individuals and between arms. | Weeks 0, 5, 10 and 14 | No |
Secondary | Sleep Quality and Daily Activity | Sleep quality and daily activity will be measured using Actiwatch. Changes will be explored within individuals and between groups. | Weeks 0, 5, 10, and 14 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05659862 -
Digitally Assisted Behavioral Physical Activity Intervention in Fibromyalgia
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT03042728 -
Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program
|
N/A | |
Recruiting |
NCT06097091 -
Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia
|
N/A | |
Recruiting |
NCT04554784 -
Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia
|
N/A | |
Completed |
NCT03300635 -
Metabolism, Muscle Function and Psychological Factors in Fibromyalgia
|
N/A | |
Recruiting |
NCT06166563 -
Exercise, Irritable Bowel Syndrome and Fibromyalgia
|
N/A | |
Completed |
NCT03166995 -
Postural Exercises in Women With Fibromyalgia
|
N/A | |
Completed |
NCT03227952 -
Sensory Stimulation in Fibromyalgia
|
N/A | |
Recruiting |
NCT06237595 -
Vagus Nerve Stimulation in Fibromyalgia
|
N/A | |
Completed |
NCT01888640 -
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
|
N/A | |
Completed |
NCT03641495 -
Pain Education and Therapeutic Exercise for Fibromyalgia
|
N/A | |
Recruiting |
NCT05581628 -
FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
|
||
Active, not recruiting |
NCT05128162 -
Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia
|
Phase 2 | |
Completed |
NCT04674878 -
Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia
|
N/A | |
Active, not recruiting |
NCT04084795 -
Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia
|
N/A | |
Completed |
NCT03129906 -
Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients
|
N/A | |
Completed |
NCT05058911 -
Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia
|
N/A | |
Recruiting |
NCT04571528 -
Effectiveness of VIRTUAL FIBROWALK STUDY
|
N/A | |
Recruiting |
NCT04571853 -
New Educational Tool for FM
|
N/A |